Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: eico20 who wrote (1778)	3/28/2016 1:11:41 PM
From: mokelumne river	Read Replies (1) \| Respond to of 2026

Eman, yes the thought of another Abbott/Mylan has crossed my mind. Looks to me like Canada/Mylan might wait for the FDA's decision. Do you recall what the company will file with the FDA in terms of Vitaros? Cold chain with a modified dispenser? At one time I presumed that the company would file with the RTD version. I mentioned delisting in my post. I forget that Denner might have an interest in keeping the price above a buck occasionally to avoid that scenario.